Ananda Immunotherapies is a clinical-stage biotech, developing next generation therapies focused on immune tolerance. Our technology aims to harness the power of regulatory T-cells or T Regs to reverse autoimmunity and restore the immune system to a healthy balance.

Our novelty relies on our ability to understand immune processes not as isolated mechanisms, but rather as integrated components of a network of networks – the immunome. Unlike immune suppression, this has potential to reverse and potentially even cure disease.

We have a pipeline of tolerance candidates for different autoimmune diseases.

For more information, please contact us at: info@ai-therapies.com​